Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies. Oncotelic’s necroptosis therapeutics work by disrupting tumor blood flow resulting in immunogenic tumor cell death through “death receptor” activation which can...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr....
Leading Life Sciences AI Platform enables strategic decision-making and targeted communication with real-time analytics on KOL/HCP product perception in Spring 2024 Release
Sorcero, the leading provider of advanced AI solutions purpose-built for life sciences, announced the release of Scientific Sentiment, enabling Life Sciences teams, for the first time, to quantify...
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and versatility, it promises to transform healthcare worldwide. The Global...
Data is everywhere, but insight is rare. Insights are hidden deep in the data and require tons of work and time to dig out. Knowledge professionals in clinical trials, medical, strategy, and regulatory affairs are struggling with the rapid growth of data — it's everywhere and it's overwhelming. One...
Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular Systems Biology
Envisagenics, an AI-driven biotechnology company, announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study demonstrates...
Tenured Life Sciences Executive Joins AI-Driven Drug Discovery Company to Provide Strategic Guidance and Support Pipeline Growth
Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, announced the appointment of Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. In this role, Dr. Aspeslet will provide...
Xaira is an integrated biotechnology company built to deliver on the promise of emerging AI tools to help transform the drug discovery and development process, providing more effective therapies to patients faster.
Xaira Therapeutics launched on a mission to help re-engineer the way we discover and develop medicines through the...
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of time
Epitel, a leader in AI technologies for patient-focused brain health solutions, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearances for two new innovative technologies: REMI™ Remote EEG...
Advanced Intake™ demonstrates efficiency gains of up to 65% in adverse event recording and 90% accuracy and quality of data extraction
ArisGlobal , an innovative life sciences technology company and developer of LifeSphere®, announced details of its Advanced Intake solution , based on LifeSphere NavaX, the next-generation advanced cognitive computing engine of the...
